BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 11046142)

  • 1. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
    Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
    Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
    Fang S; Jensen JP; Ludwig RL; Vousden KH; Weissman AM
    J Biol Chem; 2000 Mar; 275(12):8945-51. PubMed ID: 10722742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination of p53 at multiple sites in the DNA-binding domain.
    Chan WM; Mak MC; Fung TK; Lau A; Siu WY; Poon RY
    Mol Cancer Res; 2006 Jan; 4(1):15-25. PubMed ID: 16446403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6.
    Camus S; Higgins M; Lane DP; Lain S
    FEBS Lett; 2003 Feb; 536(1-3):220-4. PubMed ID: 12586367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.
    Xirodimas DP; Stephen CW; Lane DP
    Exp Cell Res; 2001 Oct; 270(1):66-77. PubMed ID: 11597128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway.
    Nakajima T; Morita K; Tsunoda H; Imajoh-Ohmi S; Tanaka H; Yasuda H; Oda K
    J Biol Chem; 1998 Aug; 273(32):20036-45. PubMed ID: 9685342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53-Mdm2 module and the ubiquitin system.
    Michael D; Oren M
    Semin Cancer Biol; 2003 Feb; 13(1):49-58. PubMed ID: 12507556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
    Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
    Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
    Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
    Brignone C; Bradley KE; Kisselev AF; Grossman SR
    Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.
    Heessen S; Leonchiks A; Issaeva N; Sharipo A; Selivanova G; Masucci MG; Dantuma NP
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1532-7. PubMed ID: 11805282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; LaĆ­n S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
    Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
    Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.
    Nakamura S; Roth JA; Mukhopadhyay T
    Mol Cell Biol; 2000 Dec; 20(24):9391-8. PubMed ID: 11094089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.
    Sionov RV; Coen S; Goldberg Z; Berger M; Bercovich B; Ben-Neriah Y; Ciechanover A; Haupt Y
    Mol Cell Biol; 2001 Sep; 21(17):5869-78. PubMed ID: 11486026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmically "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation.
    Zaika A; Marchenko N; Moll UM
    J Biol Chem; 1999 Sep; 274(39):27474-80. PubMed ID: 10488081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 promotes ubiquitination and degradation of MDMX.
    Pan Y; Chen J
    Mol Cell Biol; 2003 Aug; 23(15):5113-21. PubMed ID: 12860999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of p53 by Mdm2: fate is in the numbers.
    Shmueli A; Oren M
    Mol Cell; 2004 Jan; 13(1):4-5. PubMed ID: 14731389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of p53 stability by Mdm2.
    Kubbutat MH; Jones SN; Vousden KH
    Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21.
    Nakanishi Y; Pei XH; Takayama K; Bai F; Izumi M; Kimotsuki K; Inoue K; Minami T; Wataya H; Hara N
    Am J Respir Cell Mol Biol; 2000 Jun; 22(6):747-54. PubMed ID: 10837373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.